Q3 EPS Estimates for ProAssurance Lowered by Zacks Research

Key Points

• Zacks Research has reduced its Q3 2025 earnings estimates for ProAssurance to $0.28 per share, down from $0.30, while maintaining a "Hold" rating on the stock.
• The company recently reported strong quarterly earnings of $0.52 EPS, exceeding analysts' expectations, but its revenue dropped 19.9% year-over-year.
• Institutional investors own 85.58% of ProAssurance's stock, with substantial recent increases in stakes from several hedge funds.

ProAssurance Corporation (NYSE:PRA - Free Report) - Zacks Research lowered their Q3 2025 earnings per share (EPS) estimates for ProAssurance in a research report issued on Tuesday, August 26th. Zacks Research analyst Team now anticipates that the insurance provider will post earnings of $0.28 per share for the quarter, down from their previous forecast of $0.30. Zacks Research has a "Hold" rating on the stock. The consensus estimate for ProAssurance's current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance's Q2 2026 earnings at $0.27 EPS, Q3 2026 earnings at $0.29 EPS, Q4 2026 earnings at $0.27 EPS, Q1 2027 earnings at $0.28 EPS, Q2 2027 earnings at $0.33 EPS and FY2027 earnings at $1.25 EPS.

ProAssurance (NYSE:PRA - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The insurance provider reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.33. The company had revenue of $271.94 million for the quarter, compared to analysts' expectations of $266.72 million. ProAssurance had a return on equity of 5.62% and a net margin of 4.33%.ProAssurance's revenue for the quarter was down 19.9% compared to the same quarter last year. During the same period last year, the firm posted $0.23 EPS.

PRA has been the topic of a number of other research reports. Wall Street Zen started coverage on shares of ProAssurance in a research report on Monday, May 19th. They issued a "hold" rating on the stock. Piper Sandler lifted their price objective on ProAssurance from $18.00 to $25.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Five investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Reduce" and a consensus target price of $21.50.

ProAssurance Price Performance

NYSE PRA traded down $0.04 on Friday, reaching $23.78. 523,107 shares of the company's stock traded hands, compared to its average volume of 643,295. The stock has a market cap of $1.22 billion, a PE ratio of 25.29 and a beta of 0.12. ProAssurance has a 12 month low of $12.43 and a 12 month high of $24.14. The stock has a 50-day simple moving average of $23.70 and a 200 day simple moving average of $22.05. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.26 and a quick ratio of 0.26.

Institutional Trading of ProAssurance

A number of hedge funds have recently modified their holdings of PRA. Russell Investments Group Ltd. increased its stake in shares of ProAssurance by 356.2% in the 2nd quarter. Russell Investments Group Ltd. now owns 1,405 shares of the insurance provider's stock worth $32,000 after acquiring an additional 1,097 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of ProAssurance during the first quarter valued at approximately $47,000. GAMMA Investing LLC lifted its holdings in shares of ProAssurance by 307.3% during the first quarter. GAMMA Investing LLC now owns 2,073 shares of the insurance provider's stock valued at $48,000 after purchasing an additional 1,564 shares during the last quarter. CWM LLC boosted its position in shares of ProAssurance by 95.9% in the 1st quarter. CWM LLC now owns 2,204 shares of the insurance provider's stock worth $51,000 after purchasing an additional 1,079 shares in the last quarter. Finally, Longfellow Investment Management Co. LLC purchased a new stake in shares of ProAssurance in the 1st quarter worth approximately $75,000. Institutional investors own 85.58% of the company's stock.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.